NurExone Biologic Inc. (TSXV:NRX)
Canada · Delayed Price · Currency is CAD 0.6500
+0.0100 (1.56%)
At close: Jan 9, 2026
3.17% (1Y)
| Market Cap | 58.94M |
| Revenue (ttm) | n/a |
| Net Income (ttm) | -9.10M |
| Shares Out | 90.68M |
| EPS (ttm) | -0.12 |
| PE Ratio | n/a |
| Forward PE | n/a |
| Dividend | n/a |
| Ex-Dividend Date | n/a |
| Volume | 8,127 |
| Average Volume | 17,198 |
| Open | 0.6600 |
| Previous Close | 0.6400 |
| Day's Range | 0.6500 - 0.6600 |
| 52-Week Range | 0.5400 - 1.1400 |
| Beta | 0.23 |
| RSI | 42.29 |
| Earnings Date | Mar 30, 2026 |